Back to results
US 2007/0178086 A1Published application
Monoclonal antibody against ABCA1
AssigneeBaker Medical Research Institute
InventorsDmitri Sviridov, Nigora Mukhamedova, Ying Fu
Life of this patent
Estimating the term…
Abstract
The present invention provides a binding domain of ABCA1, wherein binding of a ligand to the domain is capable of modulating the biological activity of ABCA1. Also provided are methods for screening compounds capable of modulating ABCA1 activity, and antibodies useful in modulating ABCA1 activity.
Claims34
A binding domain of ABCA1, wherein binding of a ligand to the domain is capable of modulating a biological activity of ABCA1.
Dependencies are inferred from the claim text.